Nana Aviaaja Lippert Rosenø

Drug survival of biologics and novel immunomodulators for rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, and psoriasis - A nationwide cohort study from the DANBIO and DERMBIO registries

Alexander Egeberg, Nana Aviaaja Lippert Rosenø, David Thein et al. · Seminars in Arthritis and Rheumatism · 2022 · 84 citations

Inflammation, Rheumatology, Rheumatoid Disorder +12

Exploring disease comorbidities and temporal disease progression of psoriasis: an observational, retrospective, multi-database, cohort study

Nana Aviaaja Lippert Rosenø, Erik Hillo Lørup, Craig Richardson et al. · British Journal of Dermatology · 2022 · 19 citations · Full text

Drug Survival of Adalimumab, Secukinumab, and Ustekinumab in Psoriasis as Determined by Either Dose Escalation or Drug Discontinuation during the First 3 Years of Treatment – a Nationwide Cohort Study

David Thein, Nana Aviaaja Lippert Rosenø, Julia‐Tatjana Maul et al. · Journal of Investigative Dermatology · 2023 · 16 citations · Full text

Biomarkers of systemic inflammation are associated with disease severity and metabolic syndrome in patients with hidradenitis suppurativa

Nikolaj Holgersen, Valdemar Wendelboe Nielsen, Nana Aviaaja Lippert Rosenø et al. · JAAD International · 2024 · 16 citations · Full text